Rock Creek Group LP Purchases 581 Shares of Colgate-Palmolive (NYSE:CL)

Rock Creek Group LP grew its position in Colgate-Palmolive (NYSE:CL) by 41.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 1,973 shares of the company’s stock after acquiring an additional 581 shares during the period. Rock Creek Group LP’s holdings in Colgate-Palmolive were worth $161,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. BlackRock Inc. increased its holdings in Colgate-Palmolive by 5.1% in the first quarter. BlackRock Inc. now owns 61,053,242 shares of the company’s stock valued at $4,812,829,000 after purchasing an additional 2,946,033 shares during the period. Massachusetts Financial Services Co. MA grew its holdings in Colgate-Palmolive by 9.5% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 40,166,201 shares of the company’s stock worth $3,166,302,000 after acquiring an additional 3,475,832 shares during the period. Geode Capital Management LLC grew its holdings in Colgate-Palmolive by 1.6% during the 1st quarter. Geode Capital Management LLC now owns 13,967,241 shares of the company’s stock worth $1,098,365,000 after acquiring an additional 216,446 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in Colgate-Palmolive by 306.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 6,263,673 shares of the company’s stock worth $493,765,000 after acquiring an additional 4,724,331 shares during the period. Finally, Nuveen Asset Management LLC grew its holdings in Colgate-Palmolive by 2.2% during the 1st quarter. Nuveen Asset Management LLC now owns 5,944,407 shares of the company’s stock worth $468,598,000 after acquiring an additional 128,030 shares during the period. Institutional investors and hedge funds own 76.28% of the company’s stock.

Shares of NYSE CL opened at $77.30 on Wednesday. Colgate-Palmolive has a fifty-two week low of $74.14 and a fifty-two week high of $86.41. The stock has a market cap of $65.20 billion, a price-to-earnings ratio of 24.23, a PEG ratio of 3.98 and a beta of 0.60. The company has a debt-to-equity ratio of 9.22, a quick ratio of 0.70 and a current ratio of 1.11. The firm’s 50-day simple moving average is $79.95 and its 200 day simple moving average is $80.27.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Thursday, July 29th. The company reported $0.80 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.80. Colgate-Palmolive had a net margin of 15.98% and a return on equity of 293.48%. The business had revenue of $4.26 billion for the quarter, compared to analysts’ expectations of $4.24 billion. During the same quarter last year, the firm earned $0.74 EPS. The firm’s revenue for the quarter was up 9.3% compared to the same quarter last year. On average, sell-side analysts predict that Colgate-Palmolive will post 3.23 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 15th. Investors of record on Thursday, October 21st will be given a $0.45 dividend. The ex-dividend date is Wednesday, October 20th. This represents a $1.80 annualized dividend and a yield of 2.33%. Colgate-Palmolive’s payout ratio is 58.82%.

A number of analysts have weighed in on the company. Evercore ISI reiterated a “buy” rating and set a $95.00 price target on shares of Colgate-Palmolive in a report on Sunday, June 20th. UBS Group assumed coverage on Colgate-Palmolive in a report on Wednesday, June 23rd. They set a “buy” rating and a $95.00 price target for the company. Deutsche Bank Aktiengesellschaft reduced their target price on Colgate-Palmolive from $86.00 to $84.00 and set a “hold” rating for the company in a research note on Monday, August 2nd. Finally, Credit Suisse Group upgraded Colgate-Palmolive from a “neutral” rating to an “outperform” rating and raised their target price for the company from $80.00 to $95.00 in a research note on Wednesday, June 9th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $85.54.

In other Colgate-Palmolive news, Director Lorrie M. Norrington sold 1,898 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, August 4th. The shares were sold at an average price of $78.02, for a total transaction of $148,081.96. Following the transaction, the director now owns 24,602 shares of the company’s stock, valued at approximately $1,919,448.04. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Jennifer Daniels sold 20,290 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 5th. The stock was sold at an average price of $79.11, for a total transaction of $1,605,141.90. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.

Featured Article: Operating Income

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.